Europe seeks to address "inconsistent" IVF testing and calls for QA in PGD
This article was originally published in Clinica
Couples undergoing IVF treatment are frequently travelling across internal European borders and into the EU from non-EU states to have embryos screened for serious genetic disorders. This highlight a lack of uniformity in the type of tests that are offered by IVF services.
You may also be interested in...
A medtech industry group is asking the Trump administration to clarify if small medical device companies that have equity investors qualify for small business loans and forgiveness under the coronavirus relief package.
Amarin had argued that Vascepa’s sales success showed that its patents were not obvious, but the court found otherwise, even as it concluded that Hikma, Dr. Reddy's and West-Ward has infringed on the fish oil pill's patents.
Grail announced results from an initial validation study that showed its early-detection blood test could identify 12 of the deadliest cancers with a low rate of false-positive results.